Rhesus monkey cardiosphere-derived cells for myocardial restoration

Andreas Martens1, Ina Gruh, Dimitrios Dimitroulis

  • 1Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany. martens.andreas@mh-hannover.de

Cytotherapy
|August 17, 2011
PubMed

Insights

Rhesus monkey cardiosphere-derived cells (RhCDC) proliferated in vivo and improved cardiac function after myocardial infarction. While RhCDC showed superior regenerative effects, a paracrine mechanism involving non-cellular factors was suggested.

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Stem Cell Therapy

Background:

  • Cardiosphere-derived cells (CDC) are a potential source for cardiac repair.
  • The efficacy of CDC for myocardial restoration remains debated.
  • Rhesus monkey CDC (RhCDC) have not been previously investigated in myocardial infarction models.

Purpose of the Study:

  • To evaluate the survival, differentiation, and functional impact of RhCDC in a mouse model of myocardial infarction.
  • To compare the effects of RhCDC with placebo and medium treatment.
  • To elucidate the therapeutic mechanisms of RhCDC in cardiac repair.

Main Methods:

  • RhCDC were isolated, characterized, and transplanted into SCID beige mice post-myocardial infarction.
  • Left ventricular function was assessed using pressure-volume loop analysis.
  • Cellular differentiation was analyzed via immunohistochemistry and RT-PCR.

Main Results:

  • Transplanted RhCDC grafts proliferated in the infarcted myocardium.
  • Both RhCDC and medium treatment improved left ventricular function and protected the infarct area.
  • RhCDC demonstrated a superior regenerative effect compared to medium treatment alone.

Conclusions:

  • RhCDC successfully engrafted and proliferated in vivo, influencing myocardial remodeling post-infarction.
  • The observed benefits suggest a significant paracrine effect, potentially mediated by non-cellular components.
  • RhCDC represent a promising cell source for sustained paracrine-based cardiac stem cell therapy.
Abstract

Related Concept Videos